EP 1353680 A2 20031022 - USE OF SLPI FOR TREATING CHRONIC INFLAMMATORY INTESTINAL DISEASES
Title (en)
USE OF SLPI FOR TREATING CHRONIC INFLAMMATORY INTESTINAL DISEASES
Title (de)
VERWENDUNG VON SLPI ZUR BEHANDLUNG CHRONISCH-ENTZÜNDLICHER DARMERKRANKUNGEN
Title (fr)
UTILISATION DE SLPI POUR TRAITER DES MALADIES INTESTINALES INFLAMMATOIRES CHRONIQUES
Publication
Application
Priority
- DE 10101793 A 20010117
- EP 0114518 W 20011211
Abstract (en)
[origin: WO02056900A2] The invention relates to the use of secretory leucocyte protease inhibitor (SLPI) or a non-pathogenic micro-organism which is capable of forming the same, and which contains a nucleic acid coding for SLPI, for treating human and animal chronic inflammatory intestinal diseases. The invention also relates to pharmaceutical compositions for oral or rectal administration, containing the active ingredient SLPI or micro-organisms expressing SLPI, and a method for producing said pharmaceutical compositions.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 35/74 (2006.01); A61K 36/06 (2006.01); A61K 38/55 (2006.01); A61K 38/57 (2006.01); A61P 1/00 (2006.01); A61P 1/04 (2006.01); C07K 14/81 (2006.01); C12N 1/16 (2006.01); C12N 1/20 (2006.01); C12N 9/99 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP US)
A61K 38/57 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); C07K 14/811 (2013.01 - EP US)
Citation (search report)
See references of WO 02056900A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02056900 A2 20020725; WO 02056900 A3 20030424; DE 10101793 A1 20020801; EP 1353680 A2 20031022; JP 2004520362 A 20040708; US 2004106564 A1 20040603
DOCDB simple family (application)
EP 0114518 W 20011211; DE 10101793 A 20010117; EP 01985389 A 20011211; JP 2002557407 A 20011211; US 25090104 A 20040105